BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 14608412)

  • 1. Hormone replacement therapy improves distal radius bone structure by endocortical mineral deposition.
    Muller ME; Webber CE; Adachi JD
    Can J Physiol Pharmacol; 2003 Oct; 81(10):952-8. PubMed ID: 14608412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral quantitative computed tomography (pQCT) is useful for monitoring bone mineral density of the patients who receive hormone replacement therapy.
    Sawada K; Morishige K; Ohmichi M; Nishio Y; Yamamoto T; Hayakawa J; Mabuchi S; Isobe A; Sasaki H; Sakata M; Tasaka K; Murata Y
    Maturitas; 2007 Apr; 56(4):343-9. PubMed ID: 17010541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial comparing hormone replacement therapy (HRT) and HRT plus calcitriol in the treatment of postmenopausal osteoporosis with vertebral fractures: benefit of the combination on total body and hip density.
    Gutteridge DH; Holzherr ML; Retallack RW; Price RI; Will RK; Dhaliwal SS; Faulkner DL; Stewart GO; Stuckey BG; Prince RL; Criddle RA; Drury PJ; Tran L; Bhagat CI; Kent GN; Jamrozik K
    Calcif Tissue Int; 2003 Jul; 73(1):33-43. PubMed ID: 14506952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Denosumab improves density and strength parameters as measured by QCT of the radius in postmenopausal women with low bone mineral density.
    Genant HK; Engelke K; Hanley DA; Brown JP; Omizo M; Bone HG; Kivitz AJ; Fuerst T; Wang H; Austin M; Libanati C
    Bone; 2010 Jul; 47(1):131-9. PubMed ID: 20399288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K; Yamamoto T; Sawada K; Ohmichi M; Tasaka K; Murata Y
    Arch Gynecol Obstet; 2003 Jun; 268(2):105-6. PubMed ID: 12768299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial comparing low-dose hormone replacement therapy and HRT plus 1alpha-OH-vitamin D3 (alfacalcidol) for treatment of postmenopausal bone loss.
    Mizunuma H; Shiraki M; Shintani M; Gorai I; Makita K; Itoga S; Mochizuki Y; Mogi H; Iwaoki Y; Kosha S; Yasui T; Ishihara O; Kurabayashi T; Kasuga Y; Hayashi K
    J Bone Miner Metab; 2006; 24(1):11-5. PubMed ID: 16369892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography.
    Boutroy S; Bouxsein ML; Munoz F; Delmas PD
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6508-15. PubMed ID: 16189253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of early postmenopausal women with no bone response to HRT: results of a five-year clinical trial.
    Komulainen M; Kröger H; Tuppurainen MT; Heikkinen AM; Honkanen R; Saarikoski S
    Osteoporos Int; 2000; 11(3):211-8. PubMed ID: 10824236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefit of hormone replacement therapy on bone mass is greater at the vertebral body than posterior processes or proximal femur.
    Duan Y; Tabensky A; DeLuca V; Seeman E
    Bone; 1997 Nov; 21(5):447-51. PubMed ID: 9356739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of trabecular bone structure with age, bone mineral density, and osteoporotic status: in vivo studies in the distal radius using high resolution magnetic resonance imaging.
    Majumdar S; Genant HK; Grampp S; Newitt DC; Truong VH; Lin JC; Mathur A
    J Bone Miner Res; 1997 Jan; 12(1):111-8. PubMed ID: 9240733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of postmenopausal bone loss with exchange for short-term HRT for 1alpha-hydroxycholecalciferol.
    Ushiroyama T; Ikeda A; Sakai M; Higashiyama T; Ueki M
    Maturitas; 2003 Jun; 45(2):119-27. PubMed ID: 12787970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
    Gallagher JC; Kable WT; Goldgar D
    Am J Med; 1991 Feb; 90(2):171-8. PubMed ID: 1847582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hormone replacement therapy on bone mineral density in postmenopausal women with primary hyperparathyroidism: four-year follow-up and comparison with healthy postmenopausal women.
    Orr-Walker BJ; Evans MC; Clearwater JM; Horne A; Grey AB; Reid IR
    Arch Intern Med; 2000 Jul; 160(14):2161-6. PubMed ID: 10904459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparisons of noninvasive bone mineral measurements in assessing age-related loss, fracture discrimination, and diagnostic classification.
    Grampp S; Genant HK; Mathur A; Lang P; Jergas M; Takada M; Glüer CC; Lu Y; Chavez M
    J Bone Miner Res; 1997 May; 12(5):697-711. PubMed ID: 9144335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of teriparatide [rhPTH(1-34)] on BMD when given to postmenopausal women receiving hormone replacement therapy.
    Ste-Marie LG; Schwartz SL; Hossain A; Desaiah D; Gaich GA
    J Bone Miner Res; 2006 Feb; 21(2):283-91. PubMed ID: 16418784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the skeletal status by peripheral quantitative computed tomography of the forearm: short-term precision in vivo and comparison to dual X-ray absorptiometry.
    Grampp S; Lang P; Jergas M; Glüer CC; Mathur A; Engelke K; Genant HK
    J Bone Miner Res; 1995 Oct; 10(10):1566-76. PubMed ID: 8686514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone mass response to discontinuation of long-term hormone replacement therapy: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) Safety Follow-up Study.
    Greendale GA; Espeland M; Slone S; Marcus R; Barrett-Connor E;
    Arch Intern Med; 2002 Mar; 162(6):665-72. PubMed ID: 11911720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral quantitative Computed Tomography (PQCT) in the evaluation of bone geometry, biomechanics and mineral density in postmenopausal women.
    Di Leo C; Tarolo GL; Bagni B; Bestetti A; Tagliabue L; Pietrogrande L; Pepe L
    Radiol Med; 2002 Mar; 103(3):233-41. PubMed ID: 11976620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of long-term postmenopausal hormone-replacement therapy on estimated structural bone strength: a study in discordant monozygotic twins.
    Mikkola TM; Heinonen A; Kovanen V; Cheng S; Kujala UM; Suominen H; Alén M; Puolakka J; Ankarberg-Lindgren C; Ronkainen PH; Koskenvuo M; Kaprio J; Rantanen T; Sipilä S
    J Bone Miner Res; 2011 Mar; 26(3):546-52. PubMed ID: 20878773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of hormone replacement therapy and calcitonin on bone mass in postmenopausal women.
    Meschia M; Brincat M; Barbacini P; Maini MC; Marri R; Crosignani PG
    Eur J Obstet Gynecol Reprod Biol; 1992 Oct; 47(1):53-7. PubMed ID: 1330761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.